KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,755,070 | -39.4% | 126,264 | +0.2% | 0.00% | -100.0% |
| Q2 2023 | $2,898,027 | -89.9% | 126,056 | -87.0% | 0.00% | -83.3% |
| Q1 2023 | $28,621,615 | +15.8% | 965,967 | -2.4% | 0.01% | 0.0% |
| Q4 2022 | $24,709,551 | +10.7% | 989,966 | -3.4% | 0.01% | +20.0% |
| Q3 2022 | $22,318,000 | +10.6% | 1,025,244 | +0.1% | 0.01% | 0.0% |
| Q2 2022 | $20,175,000 | -30.5% | 1,024,662 | +49.3% | 0.01% | -16.7% |
| Q1 2022 | $29,041,000 | -13.8% | 686,194 | +29.3% | 0.01% | 0.0% |
| Q4 2021 | $33,696,000 | +14.5% | 530,718 | +6.0% | 0.01% | 0.0% |
| Q3 2021 | $29,422,000 | +784.6% | 500,880 | +630.4% | 0.01% | +500.0% |
| Q2 2021 | $3,326,000 | +123.4% | 68,580 | +78.9% | 0.00% | – |
| Q1 2021 | $1,489,000 | -40.3% | 38,336 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $2,496,000 | – | 40,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |